Home

Featured

Dr Yolanda Bryce
Interviews
Current Therapies and Future Options for Breast Cancer Treatment: An Interview With Yolanda Bryce, MD
Dr Bryce spoke with IO Learning about current breast cancer treatments and future options for the 1 in 8 women who will ultimately face breast cancer in their lifetime.
Interviews
Tumor-Targeted Dyes for Fluorescence-Guided Cancer Treatment: An Interview With Philip Low, MD
Dr Philip Low of On Target Laboratories discusses OTL38, a novel, tumor-targeted dye used to guide cancer surgery.
Presentation
Using Drug-Eluting Embolics
Dr Isabel Newton presents basic guidelines for the use of drug-eluting embolics.
Presentation
Intratumoral OX40/CpG Potentiates Immunologic Tumor Elimination of Breast Cancer–Origin Diffuse Liver Metastases
Dr Eric Soule presents a "CIO Best Abstract" on OX40, a receptor that causes T-cells to divide, increasing their ability to attack cancer.
Interviews
Renal Mass Biopsy: When Is it Justified and What do the Guidelines Say?
Tim McClure, MD, discussed biopsy and ablation staging, circumstances in which renal mass biopsy is necessary, and recommendations from guidelines.

CIO Spotlight

Y-90 Radioembolization: Evolving Concepts
CIO 2019 Offers Dramatic Learning Opportunities With “Case Saves and Complications”
“First of Its Kind”: Cutting-Edge Virtual Reality Thyroid Ablation Case Presented at CIO 2019
Top Pearls for Liver Therapy Presented at CIO 2019

Videos

Live Case Filming & Discussion: Radiofrequency Ablation for Bone Metastases
Pena
Radial Access in Interventional Oncology
Karen Brown
Biliary Interventions in Hepatic Malignancies
callstrom
Operator's Session in Renal Ablation and Interventions
Back to Top